Nasacort data

A post-marketing study with Nasacort in 173 patients allergic to ragweed (108 evaluable) showed that 73 percent of the treated group had moderate or complete suppression of nasal symptoms at the end of the six-week trial compared to 45 percent on placebo, a statistically significant difference. ...